Introduction
Mevalonate kinase deficiency (MKD) is a recessivelyinherited autoinflammatory condition caused by loss-of-functionMVK mutations. This gene encodes for the enzyme mevalonate kinase (MVK), which catalyzes a crucial step of the biosynthetic pathway of cholesterol and isoprenoids. The partial deficiency of enzymatic activity causes the Hyper-IgD and periodic fever syndrome (HIDS), whereas it complete deficiency provokes the Mevalonic Aciduria (MA).
Objectives
The aim of this study was to describe the clinical and genetic features of Spanish patients with MKD diagnosed during the past 15 years.
Methods
The patients' data as well as the outcome of the administered treatments were collected from charts reviews. MVK analysis was performed by Sanger-based sequencing. From a clinical point of view, the median age at the disease onset was 6 months (range 0-408), and the median duration of flares was 4.8 days (range 2-17.5). Mandatory vaccinations were identified as triggering factors for acute episodes in eleven patients (26.8%). The most prevalent manifestations during inflammatory episodes were fever (80.5%), lymphadenopathies (70.7%), abdominal pain (63.4%), diarrhea (58.5%), aphthous ulcers (53.7%) and arthralgia (51.2%). AA amyloidosis was only detected in one patient (2.4%), but had a severe course.
Results
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Conclusion
We herein provide a detailed description of the clinical and genetic features of a Spanish cohort of MKD patients carrying biallelic MVK mutations. Most of patients suffered from the mild MKD phenotype, the HIDS syndrome. Two prevalent MVK mutations, p.[(V377I)] and p.[(I268T)], were found in our cohort, and fever and lymphadenopathies were the most common features in enrolled patients. 1 Hospital Clinic, Barcelona, Spain Full list of author information is available at the end of the article
